This can lead to the dysfunctional placental secretion of vascular growth factors, including soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF), a phenomenon commonly referred to as an angiogenic imbalance [5,6], which can cause maternal vascular inflammatory syndrome, leading to the development of preeclampsia (PE) [5,7]. This evidence concerns the gene PGF and preeclampsia.